As of 2026-09-13, the Relative Valuation of Black Diamond Therapeutics Inc (BDTX) is (5.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.98 USD, the upside of Black Diamond Therapeutics Inc based on Relative Valuation is -354.8%.
The range of the Relative Valuation is (14.25) - 6.98 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 23.3x | 21.1x |
| Forward P/E multiples | 15.6x - 23.4x | 19.5x |
| Fair Price | (14.25) - 6.98 | (5.05) |
| Upside | -819.8% - 252.7% | -354.8% |
| Date | P/E |
| 2026-09-04 | -2.81 |
| 2026-09-03 | -2.78 |
| 2026-09-02 | -2.84 |
| 2026-09-01 | -2.71 |
| 2026-08-31 | -2.78 |
| 2026-08-28 | -2.96 |
| 2026-08-27 | -3.01 |
| 2026-08-26 | -3.01 |
| 2026-08-25 | -2.97 |
| 2026-08-24 | -2.86 |
| 2026-08-21 | -2.93 |
| 2026-08-20 | -2.85 |
| 2026-08-19 | -2.90 |
| 2026-08-18 | -2.73 |
| 2026-08-17 | -2.72 |
| 2026-08-14 | -2.68 |
| 2026-08-13 | -2.68 |
| 2026-08-12 | -2.78 |
| 2026-08-11 | -2.77 |
| 2026-08-10 | -2.63 |
| 2026-08-07 | -2.59 |
| 2026-08-06 | -2.55 |
| 2026-08-05 | -2.37 |
| 2026-08-04 | -2.36 |
| 2026-08-03 | -2.30 |
| 2026-07-31 | -2.24 |
| 2026-07-30 | -2.27 |
| 2026-07-29 | -2.20 |
| 2026-07-28 | -2.33 |
| 2026-07-27 | -2.29 |
| 2026-07-24 | -2.33 |
| 2026-07-23 | -2.44 |
| 2026-07-22 | -2.43 |
| 2026-07-21 | -2.48 |
| 2026-07-20 | -2.40 |
| 2026-07-17 | -2.37 |
| 2026-07-16 | -2.40 |
| 2026-07-15 | -2.40 |
| 2026-07-14 | -2.47 |
| 2026-07-13 | -2.52 |
| 2026-07-10 | -2.53 |
| 2026-07-09 | -2.49 |
| 2026-07-08 | -2.52 |
| 2026-07-07 | -2.76 |
| 2026-07-06 | -2.61 |
| 2026-07-02 | -2.67 |
| 2026-07-01 | -2.44 |
| 2026-06-30 | -2.45 |
| 2026-06-29 | -2.32 |
| 2026-06-26 | -2.27 |